Developer docs
API playgroundTry for free, no card

Search company profiles

Human Tissue Authority

Full company profile

uuid003684q

Namestring
Human Tissue Authority
Legal namestring
Human Tissue Authority
Websiteurl
hta.gov.uk
Company typeenum
Public
Founded yearint
2004
Descriptiontext

The Human Tissue Authority (HTA) is a statutory non-departmental public body of the UK Department of Health and Social Care, established under the Human Tissue Act 2004 to regulate organisations that collect, store, and use human tissue for research, teaching, training, patient treatment, organ transplantation, post-mortem examination, and public exhibitions. It operates across England, Wales, and Northern Ireland, and additionally assesses living organ donation cases in Scotland on behalf of Scottish Ministers under the Human Tissue (Scotland) Act 2006. HTA licenses more than 800 establishments spanning six regulated sectors: Post-Mortem, Anatomy, Public Display, Research, Human Application (quality and safety for patient treatment), and Organ Donation and Transplantation. Its core product set comprises sector-specific licensing, seven Codes of Practice (A-G), inspection and regulatory assessment services (on-site, virtual, and desk-based), the HTA Portal for licensing and incident reporting (HTARIs and SAEARs), and the Independent Assessor programme for living organ donation interviews. HTA's technology stack centres on a secure web portal with FIPS 140-2, Common Criteria EAL2+, and AES-NI encryption, supplemented by AI-assisted advertising compliance monitoring that raised UK fertility clinic ad compliance from 81.9% in September 2024 to 96.7% by October 2025.

HTA is funded primarily through parliamentary supply from the Department of Health and Social Care, with supplementary revenue from annual licensing fees set and published via HTA Legal Directions. It has no external shareholders and operates under an 11-member Board appointed by the Secretary of State for Health and Social Care. Leadership comprises Chief Executive Dr Colin Sullivan (appointed January 2022, ex-Food Standards Agency COO), three operational Directors (Regulation; Data, Technology & Development; Resources), and a Deputy Director for Performance and Corporate Governance. Recent strategic moves include the April 2024 enforcement of transplant offence reporting regulations, a December 2024 Director of Resources appointment, a high-profile Nottingham NHS Trust mortuary inspection, and the deployment of AI-assisted advertising compliance monitoring that flagged 2,380 unique ads from 60+ fertility clinics. Distribution to regulated establishments is delivered directly via the HTA Portal, site visits, and published guidance and inspection reports.

Short descriptiontext

The Human Tissue Authority is a UK non-departmental public body that licenses and inspects more than 800 establishments across post-mortem, anatomy, research, human application, public display, and organ donation sectors in England, Wales, and Northern Ireland.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersStratford-upon-avon, United Kingdom
HQ citystring
Stratford-upon-avon
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
human tissue regulation, healthcare licensing, regulatory compliance, organ transplantation, tissue establishment licensing
NAICS code2 codes
  • Administration of Public Health Programs923120
  • Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors92615
Product category
Healthcare Regulation
Revenue model2 records
1Licensing fees from regulated establishments
TypeLicensing Royalties
Description

The HTA generates revenue through annual licensing fees charged to establishments it regulates. The HTA licenses more than 800 establishments that store and use human tissue for purposes such as patient treatment, organ transplantation, post mortem examination, research, teaching, and public exhibitions. Fees are set annually and published through Legal Directions.

hta.gov.uk
2Government funding
TypeSubscription Recurring
Description

As a non-departmental public body of the Department of Health and Social Care, the HTA receives government funding for its regulatory operations.

hta.gov.uk
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Pricing details2 tiers
1Licence application and variation fees for regulated establishments
ModelOtherBilling cadenceAnnual
Notes

Fees are set annually. For establishments requiring HTA import or export licences following Brexit, no licence fee was required for 2021/22. The HTA announces licence fees annually, typically in December for the following financial year.

hta.gov.uk
2Satellite premise licensing fees
ModelOtherBilling cadenceAnnual
Notes

The Licence Holder (LH) must accept responsibility for paying the associated licensing fees for each satellite premise.

hta.gov.uk
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Human Tissue Authority (HTA) is a UK statutory regulator that licenses and inspects establishments in England, Wales, and Northern Ireland which remove, store, use, or dispose of human tissue and organs. Operating under the Human Tissue Act 2004, it oversees six regulated sectors (post-mortem, anatomy, public display, research, human application, and organ donation) to ensure public confidence and safety in the use of human tissue.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 96.7% fertility clinic advertising compliance rate achieved through enforcement
+1 more record
Product overview1 text field

The Human Tissue Authority (HTA) is the UK regulator of human tissue and organs, operating as a non-departmental public body of the Department of Health and Social Care. The HTA does not offer a single product but rather provides a comprehensive regulatory framework with six licensing sectors covering Post-Mortem, Anatomy, Public Display, Research, Human Application (Quality and Safety), and Organ Donation and Transplantation. The HTA's regulatory portfolio includes licensing of establishments, Codes of Practice (A-G), inspection and assessment services, the HTA Portal for incident reporting, Independent Assessor training and accreditation, and incident reporting systems. The HTA licenses over 800 establishments that store and use human tissue for purposes including patient treatment, organ transplantation, post mortem examination, research, teaching, and public exhibitions.

Product and service4 records
1Establishment Licensing
CategoryHealthcare Regulation
Description

Statutory licensing of establishments that remove, store, use, or dispose of human tissue and organs, required for organisations across six regulated sectors in England, Wales and Northern Ireland.

2Codes of Practice
CategoryRegulatory Guidance
Description

Statutory codes of practice (A through G) providing guidance to professionals on the proper handling, storage, use, and disposal of human tissue and organs under the Human Tissue Act 2004.

3Inspection and Regulatory Assessment
CategoryRegulatory Compliance Services
Description

On-site inspections and regulatory assessments of licensed establishments to verify compliance with statutory standards, identify non-conformities, and enforce corrective action where required.

4Independent Assessor Services
CategoryRegulatory Services
Description

Statutory service providing independent assessment for consent decisions under the Human Tissue Act 2004, for example where a deceased person's wishes regarding organ or tissue donation need verification outside of the family.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK NDPB that oversees health and social care research, including research tissue banks — directly overlapping with HTA's Research sector. Comparable governance structure (NHS-linked NDPB), small headcount, and a regulatory remit spanning ethics review, research approval, and tissue governance that intersects HTA's Research sector.

TypeBroad incumbent
Description

England's independent regulator of health and adult social care. Directly comparable as a UK health and social care regulator with licensing, inspection, and ratings functions; significantly larger in scope and headcount. HTA's Director of Data, Technology & Development previously held senior roles at CQC for seven years.

TypeBroad incumbent
Description

Executive agency of DHSC regulating medicines, medical devices, and blood components for transfusion. Operates in adjacent UK health regulatory space, with comparable licensing/inspection powers over biological products that may be used in combination with HTA-regulated tissues and cells.

TypeOthers
Description

UK statutory regulator maintaining the official register of medical practitioners. Operates in the same UK health professional regulatory ecosystem as HTA, with comparable governance, complaints handling, and fitness-to-practise processes, though focused on individuals rather than establishments.

TypeBroad incumbent
Description

UK NDPB that provides evidence-based guidance and health technology assessment (HTA — the alternative meaning of the HTA acronym). Comparable as a UK health NDPB funded via DHSC, and conceptually adjacent to HTA's regulatory remit by sharing the 'HTA' acronym but operating in clinical/economic evaluation rather than tissue regulation.

TypeRegional player
Description

Statutory regulator covering social landlords in Scotland. Comparable as a UK NDPB-style statutory regulator with a single-country remit, analogous to how HTA operates in England/Wales/Northern Ireland while having limited delegated reach into Scotland.

7NHS Blood and Transplant (NHSBT)
TypeOthers
Description

Statutory body within the NHS that manages blood, plasma, and organ transplantation services. NHSBT operates within HTA's Human Application and Organ Donation & Transplantation sectors as a major licensed establishment, making it both a regulated entity and a key operational partner.

8Advertising Standards Authority (ASA)
TypeOthers
Description

UK advertising self-regulator that partners with HTA on fertility clinic advertising compliance. HTA's AI-powered monitoring programme is used to feed ASA enforcement actions, making ASA an enforcement counterpart rather than a direct competitor.

TypeOthers
Description

UK non-ministerial department regulating food safety and standards. HTA's CEO (Dr Colin Sullivan) was previously Chief Operating Officer at FSA, and the Director of Regulation previously headed Regulatory Delivery at FSA — making it a closely related UK regulator in terms of operating model, inspection methodology, and leadership pipeline.

TypeDirect peer
Description

UK statutory regulator of fertility treatment and embryo research under the Human Fertilisation and Embryology Act 1990. Closely comparable in mandate (health-related statutory regulation of sensitive biological activities), scale (small NDPB with ~70 staff), funding model (parliamentary grant + licence fees), and licensing/inspection approach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Human Tissue Authority

Healthcare Regulationhta.gov.uk

The Human Tissue Authority is a UK non-departmental public body that licenses and inspects more than 800 establishments across post-mortem, anatomy, research, human application, public display, and organ donation sectors in England, Wales, and Northern Ireland.

What Human Tissue Authority does

The Human Tissue Authority (HTA) is a statutory non-departmental public body of the UK Department of Health and Social Care, established under the Human Tissue Act 2004 to regulate organisations that collect, store, and use human tissue for research, teaching, training, patient treatment, organ transplantation, post-mortem examination, and public exhibitions. It operates across England, Wales, and Northern Ireland, and additionally assesses living organ donation cases in Scotland on behalf of Scottish Ministers under the Human Tissue (Scotland) Act 2006. HTA licenses more than 800 establishments spanning six regulated sectors: Post-Mortem, Anatomy, Public Display, Research, Human Application (quality and safety for patient treatment), and Organ Donation and Transplantation. Its core product set comprises sector-specific licensing, seven Codes of Practice (A-G), inspection and regulatory assessment services (on-site, virtual, and desk-based), the HTA Portal for licensing and incident reporting (HTARIs and SAEARs), and the Independent Assessor programme for living organ donation interviews. HTA's technology stack centres on a secure web portal with FIPS 140-2, Common Criteria EAL2+, and AES-NI encryption, supplemented by AI-assisted advertising compliance monitoring that raised UK fertility clinic ad compliance from 81.9% in September 2024 to 96.7% by October 2025.

HTA is funded primarily through parliamentary supply from the Department of Health and Social Care, with supplementary revenue from annual licensing fees set and published via HTA Legal Directions. It has no external shareholders and operates under an 11-member Board appointed by the Secretary of State for Health and Social Care. Leadership comprises Chief Executive Dr Colin Sullivan (appointed January 2022, ex-Food Standards Agency COO), three operational Directors (Regulation; Data, Technology & Development; Resources), and a Deputy Director for Performance and Corporate Governance. Recent strategic moves include the April 2024 enforcement of transplant offence reporting regulations, a December 2024 Director of Resources appointment, a high-profile Nottingham NHS Trust mortuary inspection, and the deployment of AI-assisted advertising compliance monitoring that flagged 2,380 unique ads from 60+ fertility clinics. Distribution to regulated establishments is delivered directly via the HTA Portal, site visits, and published guidance and inspection reports.

Human Tissue Authority firmographics

Firmographics
Name
Human Tissue Authority
Legal name
Human Tissue Authority
Website
https://hta.gov.uk
Company type
Public
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
The Human Tissue Authority is a UK non-departmental public body that licenses and inspects more than 800 establishments across post-mortem, anatomy, research, human application, public display, and organ donation sectors in England, Wales, and Northern Ireland.
Ownership category
akta.pro rank

Where Human Tissue Authority is headquartered

Location

Headquarters

HQ city
Stratford-upon-avon
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Human Tissue Authority business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Licensing fees from regulated establishments: The HTA generates revenue through annual licensing fees charged to establishments it regulates. The HTA licenses more than 800 establishments that store and use human tissue for purposes such as patient treatment, organ transplantation, post mortem examination, research, teaching, and public exhibitions. Fees are set annually and published through Legal Directions.
  2. Government funding: As a non-departmental public body of the Department of Health and Social Care, the HTA receives government funding for its regulatory operations.

Pricing tiers

ModelBillingPrice
OtherAnnualLicence application and variation fees for regulated establishments
OtherAnnualSatellite premise licensing fees

Distribution channels3 records

Marketing channels6 records

Human Tissue Authority product offering

Product offering

Core offering

The Human Tissue Authority (HTA) is a UK statutory regulator that licenses and inspects establishments in England, Wales, and Northern Ireland which remove, store, use, or dispose of human tissue and organs. Operating under the Human Tissue Act 2004, it oversees six regulated sectors (post-mortem, anatomy, public display, research, human application, and organ donation) to ensure public confidence and safety in the use of human tissue.

Product overview

The Human Tissue Authority (HTA) is the UK regulator of human tissue and organs, operating as a non-departmental public body of the Department of Health and Social Care. The HTA does not offer a single product but rather provides a comprehensive regulatory framework with six licensing sectors covering Post-Mortem, Anatomy, Public Display, Research, Human Application (Quality and Safety), and Organ Donation and Transplantation. The HTA's regulatory portfolio includes licensing of establishments, Codes of Practice (A-G), inspection and assessment services, the HTA Portal for incident reporting, Independent Assessor training and accreditation, and incident reporting systems. The HTA licenses over 800 establishments that store and use human tissue for purposes including patient treatment, organ transplantation, post mortem examination, research, teaching, and public exhibitions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Establishment Licensing Statutory licensing of establishments that remove, store, use, or dispose of human tissue and organs, required for organisations across six regulated sectors in England, Wales and Northern Ireland.
  • Codes of Practice Statutory codes of practice (A through G) providing guidance to professionals on the proper handling, storage, use, and disposal of human tissue and organs under the Human Tissue Act 2004.
  • Inspection and Regulatory Assessment On-site inspections and regulatory assessments of licensed establishments to verify compliance with statutory standards, identify non-conformities, and enforce corrective action where required.
  • Independent Assessor Services Statutory service providing independent assessment for consent decisions under the Human Tissue Act 2004, for example where a deceased person's wishes regarding organ or tissue donation need verification outside of the family.

Quantifiable outcome

  • 96.7% fertility clinic advertising compliance rate achieved through enforcement
  • +1 more outcomes

Companies that use Human Tissue Authority

Customer profile

Segments6 records

Ideal customer profiles1 record

Human Tissue Authority technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Human Tissue Authority partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Human Tissue Authority competitors and assessment

Company assessment

Direct peers

  • Health Research Authority (HRA): UK NDPB that oversees health and social care research, including research tissue banks — directly overlapping with HTA's Research sector. Comparable governance structure (NHS-linked NDPB), small headcount, and a regulatory remit spanning ethics review, research approval, and tissue governance that intersects HTA's Research sector.
  • Human Fertilisation & Embryology Authority (HFEA): UK statutory regulator of fertility treatment and embryo research under the Human Fertilisation and Embryology Act 1990. Closely comparable in mandate (health-related statutory regulation of sensitive biological activities), scale (small NDPB with ~70 staff), funding model (parliamentary grant + licence fees), and licensing/inspection approach.

Broad incumbents

  • Care Quality Commission (CQC): England's independent regulator of health and adult social care. Directly comparable as a UK health and social care regulator with licensing, inspection, and ratings functions; significantly larger in scope and headcount. HTA's Director of Data, Technology & Development previously held senior roles at CQC for seven years.
  • Medicines and Healthcare products Regulatory Agency (MHRA): Executive agency of DHSC regulating medicines, medical devices, and blood components for transfusion. Operates in adjacent UK health regulatory space, with comparable licensing/inspection powers over biological products that may be used in combination with HTA-regulated tissues and cells.
  • National Institute for Health and Care Excellence (NICE): UK NDPB that provides evidence-based guidance and health technology assessment (HTA — the alternative meaning of the HTA acronym). Comparable as a UK health NDPB funded via DHSC, and conceptually adjacent to HTA's regulatory remit by sharing the 'HTA' acronym but operating in clinical/economic evaluation rather than tissue regulation.

Others

  • General Medical Council (GMC): UK statutory regulator maintaining the official register of medical practitioners. Operates in the same UK health professional regulatory ecosystem as HTA, with comparable governance, complaints handling, and fitness-to-practise processes, though focused on individuals rather than establishments.
  • NHS Blood and Transplant (NHSBT): Statutory body within the NHS that manages blood, plasma, and organ transplantation services. NHSBT operates within HTA's Human Application and Organ Donation & Transplantation sectors as a major licensed establishment, making it both a regulated entity and a key operational partner.
  • Advertising Standards Authority (ASA): UK advertising self-regulator that partners with HTA on fertility clinic advertising compliance. HTA's AI-powered monitoring programme is used to feed ASA enforcement actions, making ASA an enforcement counterpart rather than a direct competitor.
  • Food Standards Agency (FSA): UK non-ministerial department regulating food safety and standards. HTA's CEO (Dr Colin Sullivan) was previously Chief Operating Officer at FSA, and the Director of Regulation previously headed Regulatory Delivery at FSA — making it a closely related UK regulator in terms of operating model, inspection methodology, and leadership pipeline.

Regional players

  • Scottish Housing Regulator: Statutory regulator covering social landlords in Scotland. Comparable as a UK NDPB-style statutory regulator with a single-country remit, analogous to how HTA operates in England/Wales/Northern Ireland while having limited delegated reach into Scotland.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Human Tissue Authority social profiles

Digital presence

Human Tissue Authority financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Human Tissue Authority leadership team

Management profile

Number of profiles

Human Tissue Authority funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Human Tissue Authority M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Human Tissue Authority

What does Human Tissue Authority do?

The Human Tissue Authority (HTA) is a UK statutory regulator that licenses and inspects establishments in England, Wales, and Northern Ireland which remove, store, use, or dispose of human tissue and organs. Operating under the Human Tissue Act 2004, it oversees six regulated sectors (post-mortem, anatomy, public display, research, human application, and organ donation) to ensure public confidence and safety in the use of human tissue.

Is Human Tissue Authority a public or private company?

Human Tissue Authority is a public company. It is classified as state government owned and is currently operating.

When was Human Tissue Authority founded?

Human Tissue Authority was founded in 2004. It employs 51 to 100 people.

Where is Human Tissue Authority based?

Human Tissue Authority is headquartered in Stratford-upon-avon, United Kingdom, in the Europe region.

How does Human Tissue Authority make money?

Two revenue lines are on record. Licensing fees from regulated establishments are the primary driver. The others are government funding.

Who are Human Tissue Authority's main competitors?

Direct peers on record are Health Research Authority (HRA) and Human Fertilisation & Embryology Authority (HFEA). Broad incumbents are Care Quality Commission (CQC), Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE). Others are General Medical Council (GMC), NHS Blood and Transplant (NHSBT), Advertising Standards Authority (ASA) and Food Standards Agency (FSA). Scottish Housing Regulator is listed as a regional player.

Does Human Tissue Authority have an API?

No public API is recorded for Human Tissue Authority.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooHospital criticised for failures in handling of foetusesThe Human Tissue Authority inspected Countess of Chester Hospital's mortuary and found critical and major failings, including fetuses stored in fridges instead of freezers and risks of viewing or releasing the wrong body. The hospital accepted the findings, apologized, and said procedures had been strengthened.The GuardianBodies in Nottingham NHS trust mortuary in state of ‘advanced deterioration’, inspectors sayHuman Tissue Authority inspectors found eight bodies in a state of advanced decomposition at Nottingham University Hospitals NHS Trust in March due to failures in transferring bodies to freezer storage in time, with the trust also found to have insufficient mortuary capacity. The trust, already subject to the NHS's largest-ever maternity care inquiry which found over 500 mothers and babies died or were harmed between 2012-2025, has submitted an action plan to the regulator while two men have been arrested on suspicion of misconduct in connection with mortuary operating practices.The MirrorWoman claims mum's body was 'secretly donated like piece of meat to medical science'Gwenda Higgins' daughter demanded answers after her mother's body was allegedly donated to Norwich Medical School without consent. The daughter said the signature on the consent form was suspicious, and police are investigating, with an 86-year-old man interviewed under caution.BBCBrain put in wrong body among mortuary failuresA BBC Freedom of Information request found 278 serious mortuary incidents in England, Wales, and Northern Ireland from 2014 to 2016, including 36 cases where the wrong body was released to families. Accidental damage to bodies occurred 89 times, and the Human Tissue Authority said thorough investigations are undertaken.